Dissolving Microneedles Market is expected to reach US$ 99.24 Million by 2032, at a CAGR 9.5%

As per Future Market Insights' latest industry analysis, the global dissolving microneedles market is estimated to reach US$ 40.22 Million in 2022 and is further expected to grow at a CAGR of close to 9.5% over the forecast period, totalling around US$ 99.24 Million by 2032.

Microneedles have been and continue to be a focus of research for a variety of medicinal purposes. Research on dissolving microneedles is expanding quickly, both in academic institutions and in many therapeutic clinical applications. Till December 2021, ten clinical trials employing dissolving microneedles were conducted.

Request a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15468

Clinical trials for dissolving microneedles concentrate on their therapeutic application for cosmetics, anti-infectives (mostly vaccines), cancer, and skin diseases. Thus, strong product pipeline of dissolving microneedles for numerous applications is anticipated to drive market growth for dissolving microneedles.

Furthermore, the emergence of dissolving microneedles as a better alternative to hypodermic needles for vaccination as well as for cosmetic application is boosting the demand for dissolving microneedles.

Instead of using a hypodermic needle, administering vaccines with a small patch coated in several soluble microscopic needles may result in safer, more effective vaccinations that anybody may administer.

Needles used for hypodermic injections are regarded as biomedical waste and have to be disposed off in designated containers. The needles in the patch disappear into the body as soon as it is placed into the skin, leaving only the backing, which dissolves in water.

The reusing of needles, which occurs in areas with inadequate medical facilities, would be halted by the dissolving microneedle patches. The cost of the dissolving microneedle patches would be the same as that of traditional needles and syringes.

Additionally, dissolving microneedles can offer strong market potential with on-the-go and easy-to-use/administer dosage form in a minimally invasive manner. Also, there are a significant number of patients that are needle phobic, which makes the administration of vaccines difficult. Hence, there is significant demand for minimally invasive drug delivery systems like transdermal delivery of drugs.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15468

Key Takeaways from Market Study
• By application, the wrinkle treatment segment holds approximately 84.5% market value share in 2021 and it is likely to grow at the highest CAGR over the forecast period.

• Based on distribution channel, online stores are projected to capture around 44.4% of the global market value by 2032.

• With rapidly expanding healthcare industry, Europe held a value share of around 30.7% of the global dissolving microneedles market in 2021.

• The dissolving microneedles market in South Korea is poised to grow at 6.7% during the forecast period.

• Germany's dissolving microneedles market is projected to display a growth rate of 14.1% between 2022 and 2032.

"Rising number of needle-phobic population, increasing demand for dissolving microneedles for diagnosis and monitoring, and strong product pipeline for diverse applications are set to propel the demand of dissolving microneedles across the globe," says an analyst of future market insights.

Market Competition
Major market players are constantly focusing on adopting strategies such as acquisitions, partnerships, capacity expansion, and strengthening their product portfolios and distribution networks to expand their global footprint as well as to improve their market share. For instance,
• In February 2019, CosMED Pharmaceutical doubled its microneedle production capacity to increase cosmetics product manufacturing.
• In August 2020, Nissha Co., Ltd. acquired ISO 22716 certification for its global headquarters for manufacturing and quality management of cosmetics products.

• In October 2021, Vaxess Technologies announced the grand opening of a GMP manufacturing facility. Vaxess is focused on developing a pipeline of MIMIX therapies.

Buy Now@ https://www.futuremarketinsights.com/checkout/15468

Key Market Segments Covered In Dissolving Microneedles Industry Research
By Application:
• Wrinkle Treatment
• Acne Treatment

By Distribution Channel:
• Retail Stores
• Supermarkets & Hypermarkets
• Online Stores
• Aesthetic/cosmetic clinics

About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

This release was published on openPR.